Stay updated on TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Sign up to get notified when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.

Latest updates to the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page's footer now displays revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record for the TEV-48125 chronic migraine trial is now displayed, including its eligibility criteria, treatment arms, study design, and outcome measures. It also includes study documents and record dates.SummaryDifference47%

- Check22 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2; the page remains a 403 error screen.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48125 SubQ in Chronic Migraine Prevention Clinical Trial page.